Angiopoietin Like Protein 1 (ANGPTL1) Antibody from ABBEXA LTD

Search, find, compare suppliers for anti-Angiopoietin Like Protein 1 (ANGPTL1) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityAngiopoietin Like Protein 1 (ANGPTL1)
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman, mouse, rat
Isotypen/a
Formataffinity purified
Size50 µg, 100 µg,
Concentrationn/a
ApplicationsELISA, WB
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionANGPTL1 antibody is a Rabbit polyclonal against ANGPTL1.
ImmunogenSynthesized peptide derived from the Internal region of human Angptl1.
Other NamesANGPTL1, ANG3, ANGPT3, ARP1, PSEC0154, Angiopoietin-related protein 1, Angiopoietin-3, ANG-3, Angiopoietin-like protein 1, ANGPTL1, ANGPTL1, ANGPTL1 , ANGPTL1 , ANG3, ANG3, ANG3 , ANG3 , ANGPT3, ANGPT3, ANGPT3 , ANGPT3 , ARP1, ARP1, ARP1 , ARP1 , PSEC0154, PSEC0154, PSEC0154 , PSEC0154 , Angiopoietin-related protein 1, Angiopoietin-related protein 1, Angiopoietin-related protein 1 , Angiopoietin-related protein 1 , Angiopoietin-3, Angiopoietin-3, Angiopoietin-3 , Angiopoietin-3 , ANG-3, ANG-3, ANG-3 , ANG-3 , Angiopoietin-like protein 1, Angiopoietin-like protein 1, Angiopoietin-like protein 1 , Angiopoietin-like protein 1
Gene, Accession #ANGPTL1, Gene ID: 9068, UniProt: O95841
Catalog #abx327505
Priceplease inquire
Order / More InfoAngiopoietin Like Protein 1 (ANGPTL1) Antibody from ABBEXA LTD
Product Specific Referencesn/a
ABBEXA LTD
ABBEXA LTD
ABBEXA LTD
181 Cambridge Science Park
Cambridge, CB4 0GJ UK
P: +44 (0) 1223 755950

Customer Service: info@abbexa.com
Technical Support: support@abbexa.com
Orders: orders@abbexa.com

https://www.abbexa.com

U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413

Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950


Profile of ABBEXA LTD
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.